Nonspecific membrane effects of CH-103: Hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practolol

Pharmazie

Volumn 54, Issue 5, 1999, Pages 380-384

  Varga, Edit ^a,c   Szollosi J ^a   Antal, K ^b   Kovacs P ^a   Szabo J Zs ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

4 CYCLOHEXYLAMINO 1 (1 NAPHTHYLOXY) 2 BUTANOL; ADENOSINE TRIPHOSPHATASE (CALCIUM MAGNESIUM); FLUORESCENT DYE; PRACTOLOL; PROPRANOLOL;

ANIMAL CELL; ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG STRUCTURE; HYDROPHOBICITY; NONHUMAN; PARTITION COEFFICIENT; PHARMACODYNAMICS; PHYSICAL CHEMISTRY; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION;

ADRENERGIC BETA-ANTAGONISTS; AMINO ALCOHOLS; ANIMALS; CATTLE; CHEMISTRY, PHYSICAL; FLUORESCENCE POLARIZATION; MALE; MEMBRANE FLUIDITY; PRACTOLOL; PROPRANOLOL; SEMEN; SURFACE PROPERTIES; SURFACE TENSION;

EID: 0344867043     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Smith, H. J.: J. Mol. Cell. Cardiol. 14, 495 (1982)
2. Seppala, A. J.; Saris, N.-E. L.; Gauffin, M. L.: Biochem. Pharmacol. 20, 305 (1971)
3. Lemmer, B.; Wienhold, G.; Hellenbrecht, D.; Bak, I. J.; Grobecker, H.: Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 299 (1972)
4. Godin, D. V.; Wan N G, T.; Tuchek, J. M.: Biochim. Biophys. Acta 436, 757 (1976)
5. Whittaker, M.; Wicks, R. J.; Britten, J. J.: Clin. Chim. Acta 119, 107 (1982)
6. Sakanashi, M.; Nishi, K.: Eur. J. Pharmacol. 70, 83 (1981)
7. Welman, E.: Br. J. Pharmacol. 65, 479 (1979)
8. Hieda, N.; Toki, Y.; Sugiyama, S.; Ito, T.; Satake, T.; Ozawa, T.: Cardiovasc. Res. 22, 219 (1988)
9. Street, J.; Walsh, A.: Eur. J. Pharmacol. 102, 315 (1984)
10. Szegi, J.; Szabó, J.; Szentmiklósi, J.; Harsányi, K.; Korbonits, D.: Abstr. 6th International Congress of Pharmacology, p. 376, Helsinki 1975
11. Mészáros, J.; Kelemen, K.; Marcia, R.; Kecskeméti, V.; Korbonis, D.; Kovács, G.; Szegi, J.: Arch. Int. Pharmacodyn. 262, 250 (1983)
12. Mészáros, J.; Korbonits, D.; Kovács, G.; Szegi, J.: Arch. Int. Pharmacodyn. 279, 268 (1986)
13. Szabó, J.; Nosztray, K.; Szegi, J.: Pharmacol. Res. Commun. 20, 173 (1988)
14. Szabó, J.; Nosztray, K.; Varga, E.; Szegi, J.: Acta Physiol. Hung. 75, 261 (1990).
15. Szöllösi, J.: in: Damjanovich, S.; Edidin, M.; Szöllösi, J.; Trón, L. (Eds): Mobility and proximity in biological membranes, p. 138, CRC Press, Boca Raton 1994
16. Meylan, W. M.; Howard, P. H.: J. Pharm. Sci. 84, 83 (1995)
17. KOWWIN, Octanol-Water Partition Coefficient Program for Microsoft Windows 3.1 Version 1.55, Syracuse Research Corporation, Merillane, Syracuse, NY 13210, 1997
18. Hellenbrecht, D.; Lemmer, B.; Wiethold, G.; Grobecker, H.: Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 211 (1973)
19. Woods, P. B.; Robinson, M. L.: J. Pharm. Pharmacol. 33, 172 (1981)
20. Elliott, D. H.; Elworthy, P. H.; Attwood, D.: J. Pharm. Pharmacol. 25, 188P (1973)
21. Attwood, D.; Agarwal, S. P.: J. Pharm. Pharmacol. 31, 392 (1979)
22. Attwood, D.; Florence, A. T.: Surfactant systems, Chapman and Hall, London 1983
23. Levy, J. V: Eur. J. Pharmacol. 2, 250 (1968)
24. Herbette, L.; Napolitano, C. A.; Messineo, F. C.; Katz, A. M.: Adv. Myocardiol. 5, 333 (1985)
25. Herbette, L. G.; Trumbore, M.; Chester, D. W.; Katy, A. M.: J. Mol. Cell. Cardiol. 20, 373 (1988)
26. Ondrias, K.; Stasko, A.; Jancinova, V.; Balgavy, P.: Mol. Pharmacol. 31, 97 (1987)
27. Frishman, W. H.: Am. J. Cardiol. 70, 21 (1992)
28. Marie, P. Y.; Zannad, F.; Parisot, M.; Royer, R. J.: Eur. J. Pharmacol. 163, 337 (1989)
29. Flaherty, J. T.; Weisfeldt, M. L.: Free Radical Biol. Med. 5, 409 (1988)
30. Mak, I. T.; Weglicki, W. B.: Circ. Res. 63, 262 (1988)
31. Mak, I. T.; Kramer, J. H.; Freedman, A. M.; Tse, S. Y. H.; Weglicki, W.: J. Mol. Cell. Cardiol. 22, 687 (1990)
32. Mak, I. T.; Weglicki, W.: Circ. Res. 66, 1449 (1990)
33. Benet, L. Z.; Øie, S.; Schwartz, J. B.; in: Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W.; Goodman Gilman, A. (Eds): Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., p. 1707, McGraw-Hill, New York 1996
34. Murray, K. T.; Reilly, C.; Koshakji, R. P.; Roden, D. M.; Lineberry, M. D.; Wood, A. J. J.; Siddoway, L. A.; Barbey, J. T.; Woosley, R. L.: J. Clin. Invest. 85, 836 (1990)
35. Pruett, J. K.; Walle, T.; Walle, U. K.: J. Pharmacol. Exp. Therap. 215, 539 (1980)
36. Szöllösi, J.; Takács, T.; Balázs, M.; Gáspár, R.; Mátyus, L.; Szabó, G.; Trón, L.; Resli, I.: Magyar Állatorvosok Lapja 41, 459 (1986) (Abstract in English)
37. Resli, I.; Gáspár, R.; Szabó, G.; Mátyus, L.; Damjanovich, S.: Magyar Állatorvosok Lapja 38, 38 (1983) (Abstract in English)
38. Kuhry, J. G.; Duportail, G.; Bronner, C.; Laustriat, G.: Biochim. Biophys. Acta 845, 60 (1985)
39. Shinitzky, M.; Dianoux, A. C.; Gitler, C.; Weber, G.: Biochemistry 10, 2106 (1971)